Direct-to-Patient Clinical Trials: One Small Step or a Giant Leap?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 37125861.
- Also identified by DOI 10.1158/1078-0432.CCR-23-0746 and PMC identifier 10330328.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Genome driven precision oncology has transformed the landscape of multiple cancers. However, access barriers exist. A recent study exemplified a direct-to-patient outreach program via social media through the implementation of a global program that offered free tumor genomic testing with a focus on rare cancers. See related article by Doe-Tetteh et al., p. 2445.
Medical subject headings
- Neoplasms